Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Diabetes

  Free Subscription


Articles published in Diabetologia

Retrieve available abstracts of 281 articles:
HTML format
Text format



Single Articles


    October 2017
  1. RUIJGROK C, Dekker JM, Beulens JW, Brouwer IA, et al
    Size and shape of the associations of glucose, HbA1c, insulin and HOMA-IR with incident type 2 diabetes: the Hoorn Study.
    Diabetologia. 2017 Oct 10. doi: 10.1007/s00125-017-4452.
    PubMed     Text format     Abstract available


  2. ELDING LARSSON H, Lynch KF, Lonnrot M, Haller MJ, et al
    Pandemrix(R) vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children.
    Diabetologia. 2017 Oct 9. doi: 10.1007/s00125-017-4448.
    PubMed     Text format     Abstract available


  3. SZPIGEL A, Hainault I, Carlier A, Venteclef N, et al
    Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes.
    Diabetologia. 2017 Oct 7. doi: 10.1007/s00125-017-4462.
    PubMed     Text format     Abstract available


  4. HULMAN A, Vistisen D, Glumer C, Bergman M, et al
    Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate.
    Diabetologia. 2017 Oct 6. doi: 10.1007/s00125-017-4468.
    PubMed     Text format     Abstract available


  5. INSHAW JRJ, Walker NM, Wallace C, Bottolo L, et al
    The chromosome 6q22.33 region is associated with age at diagnosis of type 1 diabetes and disease risk in those diagnosed under 5 years of age.
    Diabetologia. 2017 Oct 5. doi: 10.1007/s00125-017-4440.
    PubMed     Text format     Abstract available


  6. HOPE SV, Knight BA, Shields BM, Hill AV, et al
    Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.
    Diabetologia. 2017 Oct 5. doi: 10.1007/s00125-017-4449.
    PubMed     Text format     Abstract available


  7. LOHSE Z, Knorr S, Bytoft B, Clausen TD, et al
    Differential effects of age and sex on insulin sensitivity and body composition in adolescent offspring of women with type 1 diabetes: results from the EPICOM study.
    Diabetologia. 2017 Oct 3. doi: 10.1007/s00125-017-4458.
    PubMed     Text format     Abstract available


  8. SCARR D, Lovblom LE, Lovshin JA, Boulet G, et al
    Lower corneal nerve fibre length identifies diabetic neuropathy in older adults with diabetes: results from the Canadian Study of Longevity in Type 1 Diabetes.
    Diabetologia. 2017 Oct 3. doi: 10.1007/s00125-017-4439.
    PubMed     Text format    


    September 2017
  9. BACHMANN KN, Wang TJ
    Biomarkers of cardiovascular disease: contributions to risk prediction in individuals with diabetes.
    Diabetologia. 2017 Sep 28. doi: 10.1007/s00125-017-4442.
    PubMed     Text format     Abstract available


  10. JORSAL T, Rhee NA, Pedersen J, Wahlgren CD, et al
    Enteroendocrine K and L cells in healthy and type 2 diabetic individuals.
    Diabetologia. 2017 Sep 28. doi: 10.1007/s00125-017-4450.
    PubMed     Text format     Abstract available


  11. ISMAIL HM, Xu P, Libman IM, Becker DJ, et al
    The shape of the glucose concentration curve during an oral glucose tolerance test predicts risk for type 1 diabetes.
    Diabetologia. 2017 Sep 27. doi: 10.1007/s00125-017-4453.
    PubMed     Text format     Abstract available


  12. BATTAGLIA M, Anderson MS, Buckner JH, Geyer SM, et al
    Erratum to: Understanding and preventing type 1 diabetes through the unique working model of TrialNet.
    Diabetologia. 2017 Sep 26. doi: 10.1007/s00125-017-4446.
    PubMed     Text format    


  13. CNOP M, Klupa T, Tentolouris N, Novials A, et al
    Europe has to step up its efforts to produce innovative and safe diabetes technology.
    Diabetologia. 2017 Sep 24. doi: 10.1007/s00125-017-4455.
    PubMed     Text format    


  14. HAMMES HP
    Diabetic retinopathy: hyperglycaemia, oxidative stress and beyond.
    Diabetologia. 2017 Sep 24. doi: 10.1007/s00125-017-4435.
    PubMed     Text format     Abstract available


  15. MOLNOS S, Wahl S, Haid M, Eekhoff EMW, et al
    Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study.
    Diabetologia. 2017 Sep 21. doi: 10.1007/s00125-017-4436.
    PubMed     Text format     Abstract available


  16. FARMER AD, Pedersen AG, Brock B, Jakobsen PE, et al
    Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy. Reply to Marathe CS, Rayner CK, Jones KL, et al [letter].
    Diabetologia. 2017 Sep 17. doi: 10.1007/s00125-017-4414.
    PubMed     Text format    


  17. BONHOF GJ, Strom A, Puttgen S, Ringel B, et al
    Patterns of cutaneous nerve fibre loss and regeneration in type 2 diabetes with painful and painless polyneuropathy.
    Diabetologia. 2017 Sep 15. doi: 10.1007/s00125-017-4438.
    PubMed     Text format     Abstract available


  18. RUTTER MK
    Devoting attention to glucose variability and hypoglycaemia in type 2 diabetes.
    Diabetologia. 2017 Sep 15. doi: 10.1007/s00125-017-4421.
    PubMed     Text format     Abstract available


  19. KESER T, Gornik I, Vuckovic F, Selak N, et al
    Increased plasma N-glycome complexity is associated with higher risk of type 2 diabetes.
    Diabetologia. 2017 Sep 13. doi: 10.1007/s00125-017-4426.
    PubMed     Text format     Abstract available


  20. SJOBERG L, Kaaja R, Gissler M, Tuomilehto J, et al
    Termination of pregnancy and sterilisation in women with childhood-onset type 1 diabetes.
    Diabetologia. 2017 Sep 11. doi: 10.1007/s00125-017-4428.
    PubMed     Text format     Abstract available


  21. XU X, Bian L, Shen M, Li X, et al
    Multipeptide-coupled nanoparticles induce tolerance in 'humanised' HLA-transgenic mice and inhibit diabetogenic CD8+ T cell responses in type 1 diabetes.
    Diabetologia. 2017 Sep 8. doi: 10.1007/s00125-017-4419.
    PubMed     Text format     Abstract available


  22. OMETTO G, Assheton P, Caliva F, Chudzik P, et al
    Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy.
    Diabetologia. 2017 Sep 7. doi: 10.1007/s00125-017-4424.
    PubMed     Text format     Abstract available


  23. KELLY CB, Hookham MB, Yu JY, Lockhart SM, et al
    Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes.
    Diabetologia. 2017 Sep 5. doi: 10.1007/s00125-017-4415.
    PubMed     Text format     Abstract available


  24. VISKARI H, Oikarinen S, Hoppu S, Vuorinen T, et al
    Live attenuated enterovirus vaccine (OPV) is not associated with islet autoimmunity in children with genetic susceptibility to type 1 diabetes: prospective cohort study.
    Diabetologia. 2017 Sep 2. doi: 10.1007/s00125-017-4410.
    PubMed     Text format     Abstract available


  25. VOUILLARMET J, Moret M, Morelec I, Michon P, et al
    Application of white blood cell SPECT/CT to predict remission after a 6 or 12 week course of antibiotic treatment for diabetic foot osteomyelitis.
    Diabetologia. 2017 Sep 2. doi: 10.1007/s00125-017-4417.
    PubMed     Text format     Abstract available


    August 2017
  26. DAWED AY, Ali A, Zhou K, Pearson ER, et al
    Evidence-based prioritisation and enrichment of genes interacting with metformin in type 2 diabetes.
    Diabetologia. 2017 Aug 25. doi: 10.1007/s00125-017-4404.
    PubMed     Text format     Abstract available


  27. KARSTOFT K, Clark MA, Jakobsen I, Knudsen SH, et al
    Glucose effectiveness, but not insulin sensitivity, is improved after short-term interval training in individuals with type 2 diabetes mellitus: a controlled, randomised, crossover trial.
    Diabetologia. 2017 Aug 25. doi: 10.1007/s00125-017-4406.
    PubMed     Text format     Abstract available


  28. DOVC K, Macedoni M, Bratina N, Lepej D, et al
    Closed-loop glucose control in young people with type 1 diabetes during and after unannounced physical activity: a randomised controlled crossover trial.
    Diabetologia. 2017 Aug 24. doi: 10.1007/s00125-017-4395.
    PubMed     Text format     Abstract available


  29. ELEUTERI A, Fisher AC, Broadbent DM, Garcia-Finana M, et al
    Individualised variable-interval risk-based screening for sight-threatening diabetic retinopathy: the Liverpool Risk Calculation Engine.
    Diabetologia. 2017 Aug 24. doi: 10.1007/s00125-017-4386.
    PubMed     Text format     Abstract available


  30. SCHMID V, Wagner R, Sailer C, Fritsche L, et al
    Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study.
    Diabetologia. 2017 Aug 24. doi: 10.1007/s00125-017-4407.
    PubMed     Text format     Abstract available


  31. VAN MEGEN KM, Spindler MP, Keij FM, Bosch I, et al
    Relapsing/remitting type 1 diabetes.
    Diabetologia. 2017 Aug 23. doi: 10.1007/s00125-017-4403.
    PubMed     Text format     Abstract available


  32. SIMMONS RK, Griffin SJ, Lauritzen T, Sandbaek A, et al
    Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009.
    Diabetologia. 2017 Aug 23. doi: 10.1007/s00125-017-4299.
    PubMed     Text format     Abstract available


  33. FELDMAN AL, Griffin SJ, Fharm E, Norberg M, et al
    Screening for type 2 diabetes: do screen-detected cases fare better?
    Diabetologia. 2017 Aug 23. doi: 10.1007/s00125-017-4402.
    PubMed     Text format     Abstract available


  34. SIMMONS RK, Griffin SJ, Witte DR, Borch-Johnsen K, et al
    Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults.
    Diabetologia. 2017 Aug 23. doi: 10.1007/s00125-017-4323.
    PubMed     Text format     Abstract available


  35. SIMMONS D, Zgibor JC
    Should we screen for type 2 diabetes among asymptomatic individuals? Yes.
    Diabetologia. 2017 Aug 23. doi: 10.1007/s00125-017-4397.
    PubMed     Text format     Abstract available


  36. SHAW JE
    Does the evidence support population-wide screening for type 2 diabetes? No.
    Diabetologia. 2017 Aug 23. doi: 10.1007/s00125-017-4393.
    PubMed     Text format     Abstract available


  37. PELED A, Gordon B, Twig G, Mendlovic J, et al
    Immigration to Israel during childhood is associated with diabetes at adolescence: a study of 2.7 million adolescents.
    Diabetologia. 2017 Aug 19. doi: 10.1007/s00125-017-4399.
    PubMed     Text format     Abstract available


  38. BACON KL, Stuver SO, Cozier YC, Palmer JR, et al
    Perceived racism and incident diabetes in the Black Women's Health Study.
    Diabetologia. 2017 Aug 15. doi: 10.1007/s00125-017-4400.
    PubMed     Text format     Abstract available


  39. MARATHE CS, Rayner CK, Jones KL, Horowitz M, et al
    Gastrointestinal motility in people with type 1 diabetes and peripheral neuropathy.
    Diabetologia. 2017 Aug 12. doi: 10.1007/s00125-017-4391.
    PubMed     Text format    



  40. 53 rd EASD Annual Meeting of the European Association for the Study of Diabetes : Lisbon, Portugal, 11 - 15 September 2017.
    Diabetologia. 2017 Aug 9. doi: 10.1007/s00125-017-4350.
    PubMed     Text format    


  41. MCDONALD TJ, Besser RE, Perry M, Babiker T, et al
    Screening for neonatal diabetes at day 5 of life using dried blood spot glucose measurement.
    Diabetologia. 2017 Aug 5. doi: 10.1007/s00125-017-4383.
    PubMed     Text format     Abstract available


  42. HERNANDEZ C, Bogdanov P, Sola-Adell C, Sampedro J, et al
    Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.
    Diabetologia. 2017 Aug 4. doi: 10.1007/s00125-017-4388.
    PubMed     Text format     Abstract available


  43. BORG DJ, Wang R, Murray L, Tong H, et al
    The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse.
    Diabetologia. 2017 Aug 4. doi: 10.1007/s00125-017-4392.
    PubMed     Text format     Abstract available


  44. ISMAIL K, Moulton CD, Winkley K, Pickup JC, et al
    The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study.
    Diabetologia. 2017 Aug 3. doi: 10.1007/s00125-017-4367.
    PubMed     Text format     Abstract available


  45. JIA G, Whaley-Connell A, Sowers JR
    Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
    Diabetologia. 2017 Aug 3. doi: 10.1007/s00125-017-4390.
    PubMed     Text format     Abstract available


  46. PENNO G, Russo E, Garofolo M, Daniele G, et al
    Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter].
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4387.
    PubMed     Text format    


  47. LIVINGSTONE R, Boyle JG, Petrie JR
    A new perspective on metformin therapy in type 1 diabetes.
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4364.
    PubMed     Text format     Abstract available


  48. GRIFFIN SJ, Leaver JK, Irving GJ
    Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4337.
    PubMed     Text format     Abstract available


  49. BATTAGLIA M, Anderson MS, Buckner JH, Geyer SM, et al
    Understanding and preventing type 1 diabetes through the unique working model of TrialNet.
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4384.
    PubMed     Text format     Abstract available


  50. ARODA VR, Knowler WC, Crandall JP, Perreault L, et al
    Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4361.
    PubMed     Text format     Abstract available


  51. SANCHEZ-RANGEL E, Inzucchi SE
    Metformin: clinical use in type 2 diabetes.
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4336.
    PubMed     Text format     Abstract available


  52. LAEGER T, Baumeier C, Wilhelmi I, Wurfel J, et al
    FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4389.
    PubMed     Text format     Abstract available


  53. LONNROT M, Lynch KF, Elding Larsson H, Lernmark A, et al
    Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study.
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4365.
    PubMed     Text format     Abstract available


  54. HULL CM, Peakman M, Tree TIM
    Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
    Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4377.
    PubMed     Text format     Abstract available


  55. WHITE SL, Pasupathy D, Sattar N, Nelson SM, et al
    Metabolic profiling of gestational diabetes in obese women during pregnancy.
    Diabetologia. 2017 Aug 1. doi: 10.1007/s00125-017-4380.
    PubMed     Text format     Abstract available


    July 2017
  56. TONADE D, Liu H, Palczewski K, Kern TS, et al
    Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes.
    Diabetologia. 2017 Jul 28. doi: 10.1007/s00125-017-4381.
    PubMed     Text format     Abstract available


  57. HOLST C, Becker U, Jorgensen ME, Gronbaek M, et al
    Alcohol drinking patterns and risk of diabetes: a cohort study of 70,551 men and women from the general Danish population.
    Diabetologia. 2017 Jul 27. doi: 10.1007/s00125-017-4359.
    PubMed     Text format     Abstract available


  58. ARON-WISNEWSKY J, Sokolovska N, Liu Y, Comaneshter DS, et al
    The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass.
    Diabetologia. 2017 Jul 21. doi: 10.1007/s00125-017-4371.
    PubMed     Text format     Abstract available


  59. FORBES JM, Fotheringham AK
    Vascular complications in diabetes: old messages, new thoughts.
    Diabetologia. 2017 Jul 19. doi: 10.1007/s00125-017-4360.
    PubMed     Text format     Abstract available


  60. RIGALLEAU V, Blanco L, Alexandre L, Pupier E, et al
    Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious?
    Diabetologia. 2017 Jul 19. doi: 10.1007/s00125-017-4378.
    PubMed     Text format    


  61. TANG H, Dai Q, Shi W, Zhai S, et al
    SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials.
    Diabetologia. 2017 Jul 19. doi: 10.1007/s00125-017-4370.
    PubMed     Text format     Abstract available


  62. MARZINOTTO I, Liberati D, Brigatti C, Bonfanti R, et al
    Autoantibody binding in liquid phase to IL-2 in human sera is not type 1 diabetes specific.
    Diabetologia. 2017 Jul 19. doi: 10.1007/s00125-017-4376.
    PubMed     Text format    


  63. KRUSE R, Vienberg SG, Vind BF, Andersen B, et al
    Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.
    Diabetologia. 2017 Jul 18. doi: 10.1007/s00125-017-4373.
    PubMed     Text format     Abstract available


  64. KOMORITA Y, Iwase M, Fujii H, Ohkuma T, et al
    Serum adiponectin predicts fracture risk in individuals with type 2 diabetes: the Fukuoka Diabetes Registry.
    Diabetologia. 2017 Jul 18. doi: 10.1007/s00125-017-4369.
    PubMed     Text format     Abstract available


  65. MUKA T, Asllanaj E, Avazverdi N, Jaspers L, et al
    Age at natural menopause and risk of type 2 diabetes: a prospective cohort study.
    Diabetologia. 2017 Jul 18. doi: 10.1007/s00125-017-4346.
    PubMed     Text format     Abstract available


  66. BEBU I, Braffett BH, Pop-Busui R, Orchard TJ, et al
    The relationship of blood glucose with cardiovascular disease is mediated over time by traditional risk factors in type 1 diabetes: the DCCT/EDIC study.
    Diabetologia. 2017 Jul 16. doi: 10.1007/s00125-017-4374.
    PubMed     Text format     Abstract available


  67. VELAYUTHAM V, Benitez-Aguirre PZ, Craig ME, Liew G, et al
    Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes.
    Diabetologia. 2017 Jul 15. doi: 10.1007/s00125-017-4375.
    PubMed     Text format     Abstract available


  68. TAKATO T, Iwata K, Murakami C, Wada Y, et al
    Chronic administration of myristic acid improves hyperglycaemia in the Nagoya-Shibata-Yasuda mouse model of congenital type 2 diabetes.
    Diabetologia. 2017 Jul 13. doi: 10.1007/s00125-017-4366.
    PubMed     Text format     Abstract available


  69. EGAN AM, Vellinga A, Harreiter J, Simmons D, et al
    Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe.
    Diabetologia. 2017 Jul 12. doi: 10.1007/s00125-017-4353.
    PubMed     Text format     Abstract available


  70. ZOBEL EH, von Scholten BJ, Reinhard H, Persson F, et al
    Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
    Diabetologia. 2017 Jul 5. doi: 10.1007/s00125-017-4344.
    PubMed     Text format     Abstract available


    June 2017
  71. PADDOCK E, Hohenadel MG, Piaggi P, Vijayakumar P, et al
    One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans.
    Diabetologia. 2017 Jun 29. doi: 10.1007/s00125-017-4332.
    PubMed     Text format     Abstract available


  72. CHEUNG CY, Sabanayagam C, Law AK, Kumari N, et al
    Retinal vascular geometry and 6 year incidence and progression of diabetic retinopathy.
    Diabetologia. 2017 Jun 16. doi: 10.1007/s00125-017-4333.
    PubMed     Text format     Abstract available


  73. BUS P, Scharpfenecker M, Van Der Wilk P, Wolterbeek R, et al
    The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes.
    Diabetologia. 2017 Jun 15. doi: 10.1007/s00125-017-4322.
    PubMed     Text format     Abstract available


  74. REBNORD EW, Strand E, Midttun O, Svingen GFT, et al
    The kynurenine:tryptophan ratio as a predictor of incident type 2 diabetes mellitus in individuals with coronary artery disease.
    Diabetologia. 2017 Jun 13. doi: 10.1007/s00125-017-4329.
    PubMed     Text format     Abstract available


  75. PANDURU NM, Forsblom C, Saraheimo M, Thorn LM, et al
    Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.
    Diabetologia. 2017 Jun 10. doi: 10.1007/s00125-017-4328.
    PubMed     Text format     Abstract available


  76. MURPHY HR, Bell R, Cartwright C, Curnow P, et al
    Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study.
    Diabetologia. 2017 Jun 8. doi: 10.1007/s00125-017-4314.
    PubMed     Text format     Abstract available


  77. PEDDINTI G, Cobb J, Yengo L, Froguel P, et al
    Early metabolic markers identify potential targets for the prevention of type 2 diabetes.
    Diabetologia. 2017 Jun 8. doi: 10.1007/s00125-017-4325.
    PubMed     Text format     Abstract available


  78. POLCWIARTEK C, Kragholm K, Rohde C, Hashemi N, et al
    Diabetic ketoacidosis and diabetes associated with antipsychotic exposure among a previously diabetes-naive population with schizophrenia: a nationwide nested case-control study.
    Diabetologia. 2017 Jun 7. doi: 10.1007/s00125-017-4320.
    PubMed     Text format     Abstract available


  79. KNIP M
    Metabolically inactive insulin: friend or foe in the prevention of autoimmune diabetes?
    Diabetologia. 2017 Jun 3. doi: 10.1007/s00125-017-4319.
    PubMed     Text format     Abstract available


  80. ZHU M, He X, Wang XH, Qiu W, et al
    Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications.
    Diabetologia. 2017 Jun 3. doi: 10.1007/s00125-017-4316.
    PubMed     Text format     Abstract available


  81. STANCAKOVA A, Kuulasmaa T, Kuusisto J, Mohlke KL, et al
    Genetic risk scores in the prediction of plasma glucose, impaired insulin secretion, insulin resistance and incident type 2 diabetes in the METSIM study.
    Diabetologia. 2017 Jun 1. doi: 10.1007/s00125-017-4313.
    PubMed     Text format     Abstract available


    May 2017
  82. REGNELL SE, Lernmark A
    Early prediction of autoimmune (type 1) diabetes.
    Diabetologia. 2017 May 26. doi: 10.1007/s00125-017-4308.
    PubMed     Text format     Abstract available


  83. FONDI K, Wozniak PA, Howorka K, Bata AM, et al
    Retinal oxygen extraction in individuals with type 1 diabetes with no or mild diabetic retinopathy.
    Diabetologia. 2017 May 25. doi: 10.1007/s00125-017-4309.
    PubMed     Text format     Abstract available


  84. YEO L, Peakman M
    Antigen-specific immunotherapy and influenza vaccination in type 1 diabetes: timing is everything.
    Diabetologia. 2017 May 24. doi: 10.1007/s00125-017-4304.
    PubMed     Text format    


  85. STROLLO R, Vinci C, Napoli N, Pozzilli P, et al
    Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.
    Diabetologia. 2017 May 20. doi: 10.1007/s00125-017-4296.
    PubMed     Text format     Abstract available


  86. JENKS SJ, Conway BR, McLachlan S, Teoh WL, et al
    Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.
    Diabetologia. 2017 May 20. doi: 10.1007/s00125-017-4297.
    PubMed     Text format     Abstract available


  87. KAPITZA C, Dahl K, Jacobsen JB, Axelsen MB, et al
    Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial.
    Diabetologia. 2017 May 19. doi: 10.1007/s00125-017-4289.
    PubMed     Text format     Abstract available


  88. WILDING JPH
    Medication use for the treatment of diabetes in obese individuals.
    Diabetologia. 2017 May 14. doi: 10.1007/s00125-017-4288.
    PubMed     Text format     Abstract available


  89. FADINI GP, Bonora BM, Avogaro A
    SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System.
    Diabetologia. 2017 May 12. doi: 10.1007/s00125-017-4301.
    PubMed     Text format     Abstract available


  90. SNOWHITE IV, Allende G, Sosenko J, Pastori RL, et al
    Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes.
    Diabetologia. 2017 May 12. doi: 10.1007/s00125-017-4294.
    PubMed     Text format     Abstract available


  91. LI C, Lumey LH
    Studies into severe famine in early life and diabetes in adulthood: the need to control for differences in participant age and location.
    Diabetologia. 2017 May 10. doi: 10.1007/s00125-017-4300.
    PubMed     Text format    


  92. KLEINWORT KJH, Amann B, Hauck SM, Hirmer S, et al
    Retinopathy with central oedema in an INS C94Y transgenic pig model of long-term diabetes.
    Diabetologia. 2017 May 8. doi: 10.1007/s00125-017-4290.
    PubMed     Text format     Abstract available


  93. STOY J, Olsen J, Park SY, Gregersen S, et al
    In vivo measurement and biological characterisation of the diabetes-associated mutant insulin p.R46Q (GlnB22-insulin).
    Diabetologia. 2017 May 6. doi: 10.1007/s00125-017-4295.
    PubMed     Text format     Abstract available


  94. NIINISTO S, Takkinen HM, Erlund I, Ahonen S, et al
    Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity.
    Diabetologia. 2017 May 4. doi: 10.1007/s00125-017-4280.
    PubMed     Text format     Abstract available


    April 2017
  95. GRONHOLM J, Pagni PP, Pham MN, Gibson CB, et al
    Metabolically inactive insulin analogue does not prevent autoimmune diabetes in NOD mice.
    Diabetologia. 2017 Apr 28. doi: 10.1007/s00125-017-4276.
    PubMed     Text format     Abstract available


  96. YOON S, Cho H, Kim J, Lee DW, et al
    Brain changes in overweight/obese and normal-weight adults with type 2 diabetes mellitus.
    Diabetologia. 2017 Apr 27. doi: 10.1007/s00125-017-4266.
    PubMed     Text format     Abstract available


  97. SCHWARTZ AV
    Diabetes, bone and glucose-lowering agents: clinical outcomes.
    Diabetologia. 2017 Apr 27. doi: 10.1007/s00125-017-4283.
    PubMed     Text format     Abstract available


  98. THOMSEN SK, Gloyn AL
    Human genetics as a model for target validation: finding new therapies for diabetes.
    Diabetologia. 2017 Apr 26. doi: 10.1007/s00125-017-4270.
    PubMed     Text format     Abstract available


  99. LITHOVIUS R, Toppila I, Harjutsalo V, Forsblom C, et al
    Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.
    Diabetologia. 2017 Apr 24. doi: 10.1007/s00125-017-4273.
    PubMed     Text format     Abstract available


  100. BLOEM SJ, Roep BO
    The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetes.
    Diabetologia. 2017 Apr 24. doi: 10.1007/s00125-017-4284.
    PubMed     Text format     Abstract available


  101. BRUNKWALL L, Orho-Melander M
    The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Diabetologia. 2017 Apr 22. doi: 10.1007/s00125-017-4278.
    PubMed     Text format     Abstract available


  102. LECKA-CZERNIK B
    Diabetes, bone and glucose-lowering agents: basic biology.
    Diabetologia. 2017 Apr 22. doi: 10.1007/s00125-017-4269.
    PubMed     Text format     Abstract available


  103. EGAN AM, Galjaard S, Maresh MJ, Loeken MR, et al
    A core outcome set for studies evaluating the effectiveness of prepregnancy care for women with pregestational diabetes.
    Diabetologia. 2017 Apr 13. doi: 10.1007/s00125-017-4277.
    PubMed     Text format     Abstract available


  104. HULMAN A, Simmons RK, Brunner EJ, Witte DR, et al
    Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.
    Diabetologia. 2017 Apr 13. doi: 10.1007/s00125-017-4275.
    PubMed     Text format     Abstract available


  105. CNATTINGIUS S, Lindam A, Persson M
    Risks of asphyxia-related neonatal complications in offspring of mothers with type 1 or type 2 diabetes: the impact of maternal overweight and obesity.
    Diabetologia. 2017 Apr 13. doi: 10.1007/s00125-017-4279.
    PubMed     Text format     Abstract available


  106. STOEKENBROEK RM, Lokin JL, Nielen MM, Stroes ES, et al
    How common are foot problems among individuals with diabetes? Diabetic foot ulcers in the Dutch population.
    Diabetologia. 2017 Apr 13. doi: 10.1007/s00125-017-4274.
    PubMed     Text format     Abstract available


  107. HOGAN MF, Hull RL
    The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes.
    Diabetologia. 2017 Apr 10. doi: 10.1007/s00125-017-4272.
    PubMed     Text format     Abstract available


  108. SVART MV, Rittig N, Kampmann U, Voss TS, et al
    Metabolic effects of insulin in a human model of ketoacidosis combining exposure to lipopolysaccharide and insulin deficiency: a randomised, controlled, crossover study in individuals with type 1 diabetes.
    Diabetologia. 2017 Apr 7. doi: 10.1007/s00125-017-4271.
    PubMed     Text format     Abstract available


  109. BERK KA, Yahya R, Verhoeven AJ, Touw J, et al
    Effect of diet-induced weight loss on lipoprotein(a) levels in obese individuals with and without type 2 diabetes.
    Diabetologia. 2017 Apr 6. doi: 10.1007/s00125-017-4246.
    PubMed     Text format     Abstract available


  110. VAN DIEPEN JA, Robben JH, Hooiveld GJ, Carmone C, et al
    SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetes.
    Diabetologia. 2017 Apr 5. doi: 10.1007/s00125-017-4261.
    PubMed     Text format     Abstract available


  111. GURKA MJ, Golden SH, Musani SK, Sims M, et al
    Independent associations between a metabolic syndrome severity score and future diabetes by sex and race: the Atherosclerosis Risk In Communities Study and Jackson Heart Study.
    Diabetologia. 2017 Apr 4. doi: 10.1007/s00125-017-4267.
    PubMed     Text format     Abstract available


  112. SKRTIC M, Yang GK, Perkins BA, Soleymanlou N, et al
    Erratum to: Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration.
    Diabetologia. 2017 Apr 3. doi: 10.1007/s00125-017-4241.
    PubMed     Text format    


    March 2017
  113. ZANCHI C, Macconi D, Trionfini P, Tomasoni S, et al
    MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
    Diabetologia. 2017 Mar 31. doi: 10.1007/s00125-017-4248.
    PubMed     Text format     Abstract available


  114. POLLANEN PM, Lempainen J, Laine AP, Toppari J, et al
    Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Diabetologia. 2017 Mar 31. doi: 10.1007/s00125-017-4258.
    PubMed     Text format     Abstract available


  115. FOGHSGAARD S, Vedtofte L, Andreasen C, Andersen ES, et al
    Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
    Diabetologia. 2017 Mar 31. doi: 10.1007/s00125-017-4265.
    PubMed     Text format     Abstract available


  116. AZMI S, Ferdousi M, Alam U, Petropoulos IN, et al
    Small-fibre neuropathy in men with type 1 diabetes and erectile dysfunction: a cross-sectional study.
    Diabetologia. 2017 Mar 29. doi: 10.1007/s00125-017-4245.
    PubMed     Text format     Abstract available


  117. PENNO G, Russo E, Garofolo M, Daniele G, et al
    Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus.
    Diabetologia. 2017 Mar 29. doi: 10.1007/s00125-017-4251.
    PubMed     Text format     Abstract available



  118. Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study.
    Diabetologia. 2017 Mar 27. doi: 10.1007/s00125-017-4253.
    PubMed     Text format     Abstract available


  119. FRIEDRICHS P, Schlotterer A, Sticht C, Kolibabka M, et al
    Hyperglycaemic memory affects the neurovascular unit of the retina in a diabetic mouse model.
    Diabetologia. 2017 Mar 20. doi: 10.1007/s00125-017-4254.
    PubMed     Text format     Abstract available


  120. FROHNERT BI, Ide L, Dong F, Baron AE, et al
    Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY).
    Diabetologia. 2017 Mar 17. doi: 10.1007/s00125-017-4256.
    PubMed     Text format     Abstract available


  121. HATTERSLEY AT, Patel KA
    Precision diabetes: learning from monogenic diabetes.
    Diabetologia. 2017 Mar 17. doi: 10.1007/s00125-017-4226.
    PubMed     Text format     Abstract available


  122. BONNEFOND A, Froguel P
    The case for too little melatonin signalling in increased diabetes risk.
    Diabetologia. 2017 Mar 17. doi: 10.1007/s00125-017-4255.
    PubMed     Text format     Abstract available


  123. MARSHALL SM
    Precision diabetes: a realistic outlook on a promising approach.
    Diabetologia. 2017 Mar 16. doi: 10.1007/s00125-017-4244.
    PubMed     Text format    


  124. MULDER H
    Melatonin signalling and type 2 diabetes risk: too little, too much or just right?
    Diabetologia. 2017 Mar 16. doi: 10.1007/s00125-017-4249.
    PubMed     Text format     Abstract available


  125. FLOREZ JC
    Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
    Diabetologia. 2017 Mar 10. doi: 10.1007/s00125-017-4227.
    PubMed     Text format     Abstract available


  126. SIMMONS RK, Bruun NH, Witte DR, Borch-Johnsen K, et al
    Does training of general practitioners for intensive treatment of people with screen-detected diabetes have a spillover effect on mortality and cardiovascular morbidity in 'at risk' individuals with normoglycaemia? Results from the ADDITION-Denmark cl
    Diabetologia. 2017 Mar 9. doi: 10.1007/s00125-017-4230.
    PubMed     Text format     Abstract available


  127. FENG AL, Xiang YY, Gui L, Kaltsidis G, et al
    Paracrine GABA and insulin regulate pancreatic alpha cell proliferation in a mouse model of type 1 diabetes.
    Diabetologia. 2017 Mar 9. doi: 10.1007/s00125-017-4239.
    PubMed     Text format     Abstract available


  128. HANSEN TI, Olsen SE, Haferstrom EC, Sand T, et al
    Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes.
    Diabetologia. 2017 Mar 9. doi: 10.1007/s00125-017-4233.
    PubMed     Text format     Abstract available


  129. CHEN Y, Wu F, Saito E, Lin Y, et al
    Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium.
    Diabetologia. 2017 Mar 7. doi: 10.1007/s00125-017-4229.
    PubMed     Text format     Abstract available


  130. MA ZG, Yuan YP, Xu SC, Wei WY, et al
    CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats.
    Diabetologia. 2017 Mar 3. doi: 10.1007/s00125-017-4232.
    PubMed     Text format     Abstract available


    February 2017
  131. MCCARTHY MI
    Erratum to: Painting a new picture of personalised medicine for diabetes.
    Diabetologia. 2017 Feb 27. doi: 10.1007/s00125-017-4234.
    PubMed     Text format    


  132. TRICO D, Herzog RI
    Metabolic brain adaptations to recurrent hypoglycaemia may explain the link between type 1 diabetes mellitus and epilepsy and point towards future study and treatment options.
    Diabetologia. 2017 Feb 24. doi: 10.1007/s00125-017-4231.
    PubMed     Text format    


  133. GALLAGHER EJ, Zelenko Z, Tobin-Hess A, Werner U, et al
    Erratum to: Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.
    Diabetologia. 2017 Feb 23. doi: 10.1007/s00125-017-4225.
    PubMed     Text format    


  134. WILLCOX A, Richardson SJ, Walker LS, Kent SC, et al
    Germinal centre frequency is decreased in pancreatic lymph nodes from individuals with recent-onset type 1 diabetes.
    Diabetologia. 2017 Feb 17. doi: 10.1007/s00125-017-4221.
    PubMed     Text format     Abstract available


  135. BILLIONNET C, Mitanchez D, Weill A, Nizard J, et al
    Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012.
    Diabetologia. 2017 Feb 15. doi: 10.1007/s00125-017-4206.
    PubMed     Text format     Abstract available


  136. MALTESE G, Fountoulakis N, Siow RC, Gnudi L, et al
    Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria.
    Diabetologia. 2017 Feb 13. doi: 10.1007/s00125-017-4219.
    PubMed     Text format     Abstract available


  137. MCCARTHY MI
    Painting a new picture of personalised medicine for diabetes.
    Diabetologia. 2017 Feb 7. doi: 10.1007/s00125-017-4210.
    PubMed     Text format     Abstract available


    January 2017
  138. MASCITELLI L, Goldstein MR
    PCSK9 inhibition and the global diabetes epidemic.
    Diabetologia. 2017 Jan 29. doi: 10.1007/s00125-017-4217.
    PubMed     Text format    


  139. CHEN P, Piaggi P, Traurig M, Bogardus C, et al
    Differential methylation of genes in individuals exposed to maternal diabetes in utero.
    Diabetologia. 2017 Jan 26. doi: 10.1007/s00125-016-4203.
    PubMed     Text format     Abstract available


  140. FRANKS PW, Poveda A
    Lifestyle and precision diabetes medicine: will genomics help optimise the prediction, prevention and treatment of type 2 diabetes through lifestyle therapy?
    Diabetologia. 2017 Jan 25. doi: 10.1007/s00125-017-4207.
    PubMed     Text format     Abstract available


  141. ABDELSAID M, Coucha M, Hafez S, Yasir A, et al
    Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes.
    Diabetologia. 2017 Jan 23. doi: 10.1007/s00125-017-4214.
    PubMed     Text format     Abstract available


  142. LUNDBERG M, Seiron P, Ingvast S, Korsgren O, et al
    Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary? Reply to Campbell-Thompson ML, Atkinson MA, Butler AE et al [letter].
    Diabetologia. 2017 Jan 22. doi: 10.1007/s00125-017-4212.
    PubMed     Text format    


  143. FARMER AD, Pedersen AG, Brock B, Jakobsen PE, et al
    Type 1 diabetic patients with peripheral neuropathy have pan-enteric prolongation of gastrointestinal transit times and an altered caecal pH profile.
    Diabetologia. 2017 Jan 20. doi: 10.1007/s00125-016-4199.
    PubMed     Text format     Abstract available


  144. SON JW, Lee SS, Kim SR, Yoo SJ, et al
    Low muscle mass and risk of type 2 diabetes in middle-aged and older adults: findings from the KoGES.
    Diabetologia. 2017 Jan 19. doi: 10.1007/s00125-016-4196.
    PubMed     Text format     Abstract available


  145. LAW GR, Gilthorpe MS, Secher AL, Temple R, et al
    Translating HbA1c measurements into estimated average glucose values in pregnant women with diabetes.
    Diabetologia. 2017 Jan 19. doi: 10.1007/s00125-017-4205.
    PubMed     Text format     Abstract available


  146. REZZOLA S, Corsini M, Chiodelli P, Cancarini A, et al
    Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.
    Diabetologia. 2017 Jan 13. doi: 10.1007/s00125-016-4204.
    PubMed     Text format     Abstract available


  147. CAMPBELL-THOMPSON ML, Atkinson MA, Butler AE, Giepmans BN, et al
    Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary?
    Diabetologia. 2017 Jan 9. doi: 10.1007/s00125-016-4195.
    PubMed     Text format    


  148. SI J, Yu C, Guo Y, Bian Z, et al
    Season of birth and the risk of type 2 diabetes in adulthood: a prospective cohort study of 0.5 million Chinese adults.
    Diabetologia. 2017 Jan 7. doi: 10.1007/s00125-016-4200.
    PubMed     Text format     Abstract available


  149. MARROQUI L, Dos Santos RS, Op de Beeck A, Coomans de Brachene A, et al
    Interferon-alpha mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes.
    Diabetologia. 2017 Jan 6. doi: 10.1007/s00125-016-4201.
    PubMed     Text format     Abstract available


  150. ASVOLD BO, Midthjell K, Krokstad S, Rangul V, et al
    Prolonged sitting may increase diabetes risk in physically inactive individuals: an 11 year follow-up of the HUNT Study, Norway.
    Diabetologia. 2017 Jan 4. doi: 10.1007/s00125-016-4193.
    PubMed     Text format     Abstract available


    December 2016
  151. TIKKANEN-DOLENC H, Waden J, Forsblom C, Harjutsalo V, et al
    Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes.
    Diabetologia. 2016 Dec 24. doi: 10.1007/s00125-016-4189.
    PubMed     Text format     Abstract available


  152. JIANG X, Zhou Y, Wu KK, Chen Z, et al
    APPL1 prevents pancreatic beta cell death and inflammation by dampening NFkappaB activation in a mouse model of type 1 diabetes.
    Diabetologia. 2016 Dec 23. doi: 10.1007/s00125-016-4185.
    PubMed     Text format     Abstract available


  153. YUAN T, Rafizadeh S, Gorrepati KD, Lupse B, et al
    Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes.
    Diabetologia. 2016 Dec 21. doi: 10.1007/s00125-016-4188.
    PubMed     Text format     Abstract available


  154. LYTVYN Y, Xiao F, Kennedy CR, Perkins BA, et al
    Assessment of urinary microparticles in normotensive patients with type 1 diabetes.
    Diabetologia. 2016 Dec 21. doi: 10.1007/s00125-016-4190.
    PubMed     Text format     Abstract available


  155. FORRESTEL AC, Miedlich SU, Yurcheshen M, Wittlin SD, et al
    Chronomedicine and type 2 diabetes: shining some light on melatonin.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  156. QI W, Li Q, Liew CW, Rask-Madsen C, et al
    SHP-1 activation inhibits vascular smooth muscle cell proliferation and intimal hyperplasia in a rodent model of insulin resistance and diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  157. KARSTOFT K, Clark MA, Jakobsen I, Muller IA, et al
    The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  158. DEMPSEY PC, Blankenship JM, Larsen RN, Sacre JW, et al
    Interrupting prolonged sitting in type 2 diabetes: nocturnal persistence of improved glycaemic control.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  159. WONG T, Barnes RA, Ross GP, Cheung NW, et al
    Are the Institute of Medicine weight gain targets applicable in women with gestational diabetes mellitus?
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  160. DEN BIGGELAAR LJ, Sep SJ, Eussen SJ, Mari A, et al
    Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  161. SHIMA T, Matsui T, Jesmin S, Okamoto M, et al
    Moderate exercise ameliorates dysregulated hippocampal glycometabolism and memory function in a rat model of type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available



  162. Erratum to: Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
    Diabetologia. 2016.
    PubMed     Text format    


  163. JOHANSSON BB, Irgens HU, Molnes J, Sztromwasser P, et al
    Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  164. VENKATARAMAN H, Ram U, Craik S, Arungunasekaran A, et al
    Increased fetal adiposity prior to diagnosis of gestational diabetes in South Asians: more evidence for the 'thin-fat' baby.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  165. DUVIVIER BM, Schaper NC, Hesselink MK, van Kan L, et al
    Breaking sitting with light activities vs structured exercise: a randomised crossover study demonstrating benefits for glycaemic control and insulin sensitivity in type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    November 2016
  166. GOW ML, Baur LA, Johnson NA, Cowell CT, et al
    Reversal of type 2 diabetes in youth who adhere to a very-low-energy diet: a pilot study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  167. ZACCARDI F, Dhalwani NN, Papamargaritis D, Webb DR, et al
    Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 diabetes mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available



  168. Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes.
    Diabetologia. 2016.
    PubMed     Text format    


  169. SAMANDARI N, Mirza AH, Nielsen LB, Kaur S, et al
    Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  170. KIEFTE-DE JONG JC, Li Y, Chen M, Curhan GC, et al
    Diet-dependent acid load and type 2 diabetes: pooled results from three prospective cohort studies.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  171. POUWER F
    Depression: a common and burdensome complication of diabetes that warrants the continued attention of clinicians, researchers and healthcare policy makers.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  172. RAWAL S, Hinkle SN, Bao W, Zhu Y, et al
    A longitudinal study of iron status during pregnancy and the risk of gestational diabetes: findings from a prospective, multiracial cohort.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  173. HODSON K, Dalla Man C, Smith FE, Barnes A, et al
    Liver triacylglycerol content and gestational diabetes: effects of moderate energy restriction.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  174. WANG N, Cheng J, Han B, Li Q, et al
    Exposure to severe famine in the prenatal or postnatal period and the development of diabetes in adulthood: an observational study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    October 2016
  175. DAFOULAS GE, Toulis KA, Mccorry D, Kumarendran B, et al
    Type 1 diabetes mellitus and risk of incident epilepsy: a population-based, open-cohort study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  176. DANESHPAJOOH M, Bacos K, Bysani M, Bagge A, et al
    HDAC7 is overexpressed in human diabetic islets and impairs insulin secretion in rat islets and clonal beta cells.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  177. LUNDBERG M, Seiron P, Ingvast S, Korsgren O, et al
    Insulitis in human diabetes: a histological evaluation of donor pancreases.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  178. DE VRIES PS, van Herpt TT, Ligthart S, Hofman A, et al
    ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  179. KAMPLING H, Petrak F, Farin E, Kulzer B, et al
    Trajectories of depression in adults with newly diagnosed type 1 diabetes: results from the German Multicenter Diabetes Cohort Study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  180. BONIFACIO E, Mathieu C, Nepom GT, Ziegler AG, et al
    Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  181. BRAHIMAJ A, Muka T, Kavousi M, Laven JS, et al
    Serum dehydroepiandrosterone levels are associated with lower risk of type 2 diabetes: the Rotterdam Study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  182. SMITH AD, Crippa A, Woodcock J, Brage S, et al
    Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  183. REYNOLDS AN, Mann JI, Williams S, Venn BJ, et al
    Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  184. CHEUNG CY, Tang CS, Xu A, Lee CH, et al
    Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  185. DAVIDSON MB
    Diabetic retinopathy is not present in newly diagnosed diabetic patients.
    Diabetologia. 2016.
    PubMed     Text format    


  186. GROOP L
    New approaches beyond genetics: towards precision medicine in diabetes.
    Diabetologia. 2016.
    PubMed     Text format    


  187. DIPLA K, Triantafyllou A, Grigoriadou I, Kintiraki E, et al
    Impairments in microvascular function and skeletal muscle oxygenation in women with gestational diabetes mellitus: links to cardiovascular disease risk factors.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  188. DAVIS WA, Zilkens RR, Starkstein SE, Davis TM, et al
    Dementia onset, incidence and risk in type 2 diabetes: a matched cohort study with the Fremantle Diabetes Study Phase I.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  189. ADAMSKI J
    Key elements of metabolomics in the study of biomarkers of diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  190. TALEB N, Emami A, Suppere C, Messier V, et al
    Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  191. BEAM CA, MacCallum C, Herold KC, Wherrett DK, et al
    GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  192. REICHHART N, Crespo-Garcia S, Haase N, Golic M, et al
    The TetO rat as a new translational model for type 2 diabetic retinopathy by inducible insulin receptor knockdown.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  193. CUNHA JP, Leuckx G, Sterkendries P, Korf H, et al
    Human multipotent adult progenitor cells enhance islet function and revascularisation when co-transplanted as a composite pellet in a mouse model of diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    September 2016
  194. OSBORNE DM, O'Leary KE, Fitzgerald DP, George AJ, et al
    Context-dependent memory following recurrent hypoglycaemia in non-diabetic rats is mediated via glucocorticoid signalling in the dorsal hippocampus.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  195. MCKILLOP AM, Moran BM, Abdel-Wahab YH, Gormley NM, et al
    Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  196. BOZZETTO L, Costabile G, Luongo D, Naviglio D, et al
    Reduction in liver fat by dietary MUFA in type 2 diabetes is helped by enhanced hepatic fat oxidation.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  197. WU P, Kwok CS, Haththotuwa R, Kotronias RA, et al
    Pre-eclampsia is associated with a twofold increase in diabetes: a systematic review and meta-analysis.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  198. HINKLE SN, Buck Louis GM, Rawal S, Zhu Y, et al
    A longitudinal study of depression and gestational diabetes in pregnancy and the postpartum period.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  199. TANG H, Zhang X, Zhang J, Li Y, et al
    Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  200. SMITS MM, Tonneijck L, Muskiet MH, Kramer MH, et al
    Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  201. VAN DE BUNT M
    An alternative effector gene at the type 2 diabetes-associated TCF7L2 locus?
    Diabetologia. 2016.
    PubMed     Text format    



  202. Investigation of gene-diet interactions in the incretin system and risk of type 2 diabetes: the EPIC-InterAct study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  203. POPOVIC M, Blum CA, Nigro N, Mueller B, et al
    Benefit of adjunct corticosteroids for community-acquired pneumonia in diabetic patients.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  204. KARSDAL MA, Henriksen K, Genovese F, Leeming DJ, et al
    Serum endotrophin identifies optimal responders to PPARgamma agonists in type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  205. READ SH, Kerssens JJ, McAllister DA, Colhoun HM, et al
    Erratum to: Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013.
    Diabetologia. 2016.
    PubMed     Text format    


  206. SCHRAUWEN P, van Marken Lichtenbelt WD
    Combatting type 2 diabetes by turning up the heat.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  207. WILLIAMS GM, Long AE, Wilson IV, Aitken RJ, et al
    Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  208. VAN DER LEEUW J, Visseren FL, Woodward M, van der Graaf Y, et al
    Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  209. OTT C, Kistner I, Keller M, Friedrich S, et al
    Effects of linagliptin on renal endothelial function in patients with type 2 diabetes: a randomised clinical trial.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    August 2016
  210. CHACKO E
    Preventing exercise-induced hypoglycaemia in insulin-dependent diabetes.
    Diabetologia. 2016.
    PubMed     Text format    


  211. DEICHGRAEBER P, Witte DR, Moller HJ, Skriver MV, et al
    Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  212. KIESWICH J, Sayers SR, Silvestre MF, Harwood SM, et al
    Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  213. XIA Q, Chesi A, Manduchi E, Johnston BT, et al
    The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  214. GAEDE P, Oellgaard J, Carstensen B, Rossing P, et al
    Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  215. ZHAO P, Liu E, Qiao Y, Katzmarzyk PT, et al
    Maternal gestational diabetes and childhood obesity at age 9-11: results of a multinational study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  216. LAVIN DP, White MF, Brazil DP
    IRS proteins and diabetic complications.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  217. LU Y, Wang Y, Ong CN, Subramaniam T, et al
    Metabolic signatures and risk of type 2 diabetes in a Chinese population: an untargeted metabolomics study using both LC-MS and GC-MS.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  218. ZHANG M, Zhang L, Hu J, Lin J, et al
    MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  219. RICHARDSON SJ, Rodriguez-Calvo T, Gerling IC, Mathews CE, et al
    Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  220. GELLEN B, Thorin-Trescases N, Sosner P, Gand E, et al
    ANGPTL2 is associated with an increased risk of cardiovascular events and death in diabetic patients.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    July 2016
  221. FU D, Yu JY, Yang S, Wu M, et al
    Survival or death: a dual role for autophagy in stress-induced pericyte loss in diabetic retinopathy.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  222. READ SH, Kerssens JJ, McAllister DA, Colhoun HM, et al
    Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  223. MISRA S, Shields B, Colclough K, Johnston DG, et al
    South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European people.
    Diabetologia. 2016.
    PubMed     Text format    


  224. FREATHY RM
    Can genetic evidence help us to understand the fetal origins of type 2 diabetes?
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  225. MUCH D, Beyerlein A, Kindt A, Krumsiek J, et al
    Lactation is associated with altered metabolomic signatures in women with gestational diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  226. HALVORSEN B, Santilli F, Scholz H, Sahraoui A, et al
    LIGHT/TNFSF14 is increased in patients with type 2 diabetes mellitus and promotes islet cell dysfunction and endothelial cell inflammation in vitro.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  227. YUNG HW, Alnaes-Katjavivi P, Jones CJ, El-Bacha T, et al
    Placental endoplasmic reticulum stress in gestational diabetes: the potential for therapeutic intervention with chemical chaperones and antioxidants.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  228. FALL T, Salihovic S, Brandmaier S, Nowak C, et al
    Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  229. ENDESFELDER D, Hagen M, Winkler C, Haupt F, et al
    A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  230. GIBB FW, Teoh WL, Graham J, Lockman KA, et al
    Risk of death following admission to a UK hospital with diabetic ketoacidosis.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  231. BARNES RA, Wong T, Ross GP, Jalaludin BB, et al
    A novel validated model for the prediction of insulin therapy initiation and adverse perinatal outcomes in women with gestational diabetes mellitus.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  232. CUMMINGS DE
    Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy. Reply to Halpern B, Cercato C, Mancini MC [letter].
    Diabetologia. 2016.
    PubMed     Text format    


  233. JAWERBAUM A
    Placental endoplasmic reticulum stress and acidosis: relevant aspects in gestational diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  234. APOSTOLOPOULOU M, Strassburger K, Herder C, Knebel B, et al
    Metabolic flexibility and oxidative capacity independently associate with insulin sensitivity in individuals with newly diagnosed type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  235. MAYER B
    Using systems biology to evaluate targets and mechanism of action of drugs for diabetes comorbidities.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  236. PERSSON M, Cnattingius S, Wikstrom AK, Johansson S, et al
    Maternal overweight and obesity and risk of pre-eclampsia in women with type 1 diabetes or type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    June 2016
  237. THABIT H, Hovorka R
    Coming of age: the artificial pancreas for type 1 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  238. PENA MJ, Mischak H, Heerspink HJ
    Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  239. MUNDINGER TO, Taborsky GJ Jr
    Early sympathetic islet neuropathy in autoimmune diabetes: lessons learned and opportunities for investigation.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  240. WANG T, Huang T, Li Y, Zheng Y, et al
    Low birthweight and risk of type 2 diabetes: a Mendelian randomisation study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  241. HEERSPINK HJ, De Zeeuw D
    Novel anti-inflammatory drugs for the treatment of diabetic kidney disease.
    Diabetologia. 2016.
    PubMed     Text format    


  242. ABELS M, Riva M, Bennet H, Ahlqvist E, et al
    CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  243. BROSIUS FC, Tuttle KR, Kretzler M
    JAK inhibition in the treatment of diabetic kidney disease.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  244. CHERNEY D, Lund SS, Perkins BA, Groop PH, et al
    The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  245. PONTO KA, Koenig J, Peto T, Lamparter J, et al
    Prevalence of diabetic retinopathy in screening-detected diabetes mellitus: results from the Gutenberg Health Study (GHS).
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  246. CARLBOM L, Espes D, Lubberink M, Eriksson O, et al
    Pancreatic perfusion and subsequent response to glucose in healthy individuals and patients with type 1 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  247. MAESSEN DE, Hanssen NM, Lips MA, Scheijen JL, et al
    Energy restriction and Roux-en-Y gastric bypass reduce postprandial alpha-dicarbonyl stress in obese women with type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  248. HALPERN B, Cercato C, Mancini MC
    Diabetes remission off medications is not a suitable endpoint for comparing bariatric/metabolic surgery with pharmacotherapy.
    Diabetologia. 2016.
    PubMed     Text format    


  249. WANNAMETHEE SG, Welsh P, Lennon L, Papacosta O, et al
    Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  250. YU JY, Du M, Elliott MH, Wu M, et al
    Extravascular modified lipoproteins: a role in the propagation of diabetic retinopathy in a mouse model of type 1 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  251. FIORETTO P, Stefansson BV, Johnsson E, Cain VA, et al
    Dapagliflozin reduces albuminuria over 2 years in patients with type 2 diabetes mellitus and renal impairment.
    Diabetologia. 2016.
    PubMed     Text format    


  252. THABIT H, Leelarathna L
    Basal insulin delivery reduction for exercise in type 1 diabetes: finding the sweet spot.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  253. JOSEPH JJ, Echouffo-Tcheugui JB, Carnethon MR, Bertoni AG, et al
    The association of ideal cardiovascular health with incident type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    May 2016
  254. JACOBSEN R, Thorsen SU, Cohen AS, Lundqvist M, et al
    Neonatal vitamin D status is not associated with later risk of type 1 diabetes: results from two large Danish population-based studies.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  255. GALLAGHER EJ, Zelenko Z, Tobin-Hess A, Werner U, et al
    Non-metabolisable insulin glargine does not promote breast cancer growth in a mouse model of type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  256. BERENTZEN NE, Wijga AH, van Rossem L, Koppelman GH, et al
    Family history of myocardial infarction, stroke and diabetes and cardiometabolic markers in children.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  257. WU HT, Ou HY, Hung HC, Su YC, et al
    A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  258. WALTHER D, Eugster A, Jergens S, Gavrisan A, et al
    Tetraspanin 7 autoantibodies in type 1 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  259. GROTENFELT NE, Wasenius NS, Rono K, Laivuori H, et al
    Interaction between rs10830963 polymorphism in MTNR1B and lifestyle intervention on occurrence of gestational diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  260. GNUDI L
    Angiopoietins and diabetic nephropathy.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  261. COCHRAN BJ, Ryder WJ, Parmar A, Tang S, et al
    In vivo PET imaging with [F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  262. PETERS SA, Yang L, Guo Y, Chen Y, et al
    Parenthood and the risk of diabetes in men and women: a 7 year prospective study of 0.5 million individuals.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  263. CHOU IC, Kao CH
    The intriguing relationship between epilepsy and type 1 diabetes mellitus. Reply to Sander JW, Novy J, Keezer MR [letter].
    Diabetologia. 2016.
    PubMed     Text format    


  264. BENHALIMA K, Mathieu C, Damm P, Van Assche A, et al
    Erratum to: A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG).
    Diabetologia. 2016.
    PubMed     Text format    


  265. SANDER JW, Novy J, Keezer MR
    The intriguing relationship between epilepsy and type 1 diabetes mellitus.
    Diabetologia. 2016.
    PubMed     Text format    


  266. NORHAMMAR A, Bodegard J, Nystrom T, Thuresson M, et al
    Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  267. DANKNER R, Boffetta P, Keinan-Boker L, Balicer RD, et al
    Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  268. CHOW LS, Odegaard AO, Bosch TA, Bantle AE, et al
    Twenty year fitness trends in young adults and incidence of prediabetes and diabetes: the CARDIA study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  269. BAHRAMI B, Zhu M, Hong T, Chang A, et al
    Diabetic macular oedema: pathophysiology, management challenges and treatment resistance.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  270. AL-MRABEH A, Hollingsworth KG, Steven S, Taylor R, et al
    Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  271. DAMM P, Houshmand-Oeregaard A, Kelstrup L, Lauenborg J, et al
    Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  272. BERNTORP KE
    Gestational diabetes: what's up?
    Diabetologia. 2016.
    PubMed     Text format    


  273. CHOW BS, Koulis C, Krishnaswamy P, Steckelings UM, et al
    The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  274. VAARASMAKI M
    Is it worth treating gestational diabetes: if so, when and how?
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  275. MCAULEY SA, Horsburgh JC, Ward GM, La Gerche A, et al
    Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  276. ZHANG C, Rawal S, Chong YS
    Risk factors for gestational diabetes: is prevention possible?
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  277. KONG Y, Sharma RB, Nwosu BU, Alonso LC, et al
    Islet biology, the CDKN2A/B locus and type 2 diabetes risk.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  278. PRASAD RB, Lessmark A, Almgren P, Kovacs G, et al
    Excess maternal transmission of variants in the THADA gene to offspring with type 2 diabetes.
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


  279. TALEB N, Rabasa-Lhoret R
    Can somatostatin antagonism prevent hypoglycaemia during exercise in type 1 diabetes?
    Diabetologia. 2016.
    PubMed     Text format     Abstract available


    February 2016
  280. XU M, Lv X, Xie L, Huang X, et al
    Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis.
    Diabetologia. 2016;59:307-15.
    PubMed     Text format     Abstract available


  281. JHA JC, Thallas-Bonke V, Banal C, Gray SP, et al
    Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Diabetologia. 2016;59:379-89.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: